Medirom Healthcare Technologies Inc (MRM) FinancialsMRMMedirom Healthcare Technologies Inc

Medirom Healthcare Technologies Inc (MRM) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Relaxation Salon, accounting for 99.2% of total sales, equivalent to JPY 2.11B. Other significant revenue streams include Revenue from directly-operated salons and Sublease revenue. Understanding this composition is critical for investors evaluating how MRM navigates market cycles within the Personal Services industry.

Evaluating the bottom line, Medirom Healthcare Technologies Inc maintains a gross margin of 99.65%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 11.54%, while the net margin is 10.36%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively MRM converts its operational activities into shareholder value.

In the context of the broader market, MRM competes directly with industry leaders such as EJH and AMBO. With a market capitalization of $2.25M, it holds a significant position in the sector. When comparing efficiency, MRM's gross margin of 99.65% stands against EJH's 23.42% and AMBO's 51.40%. Such benchmarking helps identify whether Medirom Healthcare Technologies Inc is trading at a premium or discount relative to its financial performance.

Medirom's gross margin has shown remarkable improvement, reaching 99.65% in the last quarter, while net income has turned positive at 63,427,822 JPY for the last two quarters. However, the company has a negative P/E ratio of -0.002044 and a price-to-sales ratio of 0.000283, indicating severe undervaluation and financial distress.